The Role of Laryngopharyngeal Reflux in IPF
Recruiting now
Conditions studied: IPF, Reflux
In brief
The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).
Key facts
- Study ID
- NCT03418350
- Run by
- National Jewish Health
- People needed
- 60
- Starts
- 2018-08-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-11-14
Who can join
Age: 40 and older, up to 95. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of IPF
- Age 40-95
- Able to read, speak, and understand English
- If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.
You may not qualify if…
- Patients who do not meet all inclusion criteria
- Pregnant females
Where it is running
- National Jewish Health — Denver, Colorado, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.